These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23797323)

  • 1. Pharmacogenomics of anti-platelet and anti-coagulation therapy.
    Fisch AS; Perry CG; Stephens SH; Horenstein RB; Shuldiner AR
    Curr Cardiol Rep; 2013 Jul; 15(7):381. PubMed ID: 23797323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
    Schwalm JD; Ahmad M; Salehian O; Eikelboom JW; Natarajan MK
    J Thromb Thrombolysis; 2010 Aug; 30(2):127-32. PubMed ID: 20157843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 4. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.
    George J; Doney A; Palmer CN; Lang CC
    Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
    Leon MB; Baim DS; Popma JJ; Gordon PC; Cutlip DE; Ho KK; Giambartolomei A; Diver DJ; Lasorda DM; Williams DO; Pocock SJ; Kuntz RE
    N Engl J Med; 1998 Dec; 339(23):1665-71. PubMed ID: 9834303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents.
    Seivani Y; Abdel-Wahab M; Geist V; Richardt G; Sulimov DS; El-Mawardy M; Toelg R; Akin I
    Clin Res Cardiol; 2013 Nov; 102(11):799-806. PubMed ID: 23771774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease gets personal.
    Hayden EC
    Nature; 2009 Aug; 460(7258):940-1. PubMed ID: 19693052
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute.
    Brulotte S; Sénéchal M; Poirier P; Nguyen CM; Lemieux A; Magne J; Bergeron S
    Can J Cardiol; 2007 Oct; 23 Suppl B(Suppl B):80B-83B. PubMed ID: 17932593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes associated with combined antiplatelet and anticoagulant therapy.
    Johnson SG; Rogers K; Delate T; Witt DM
    Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
    Donohue MM; Tirschwell DL
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):52-60. PubMed ID: 21046289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
    Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
    J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
    Blann AD; Skjøth F; Rasmussen LH; Larsen TB; Lip GY
    Thromb Haemost; 2015 Aug; 114(2):403-9. PubMed ID: 26062437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.
    Ross S; Paré G
    Pharmacogenomics; 2013 Oct; 14(13):1565-72. PubMed ID: 24088127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.